For example, the selective HDAC6 inhibitor tubastatin A has been investigated for the treatment of cancer, neurodegenerative disorders, and chronic obstructive pulmonary disease and displays no obvious side effect13, 41, 42, 43. Here, HDAC6 is linked to chronic obstructive pulmonary disease.